Evidence-based path to newborn screening for duchenne muscular dystrophy-Reference-Cited by-同舟云学术

Evidence-based path to newborn screening for duchenne muscular dystrophy

Published:2012-03 Issue:3 Volume:71 Page:304-313
ISSN:0364-5134
Container-title:Annals of Neurology
language:en
Short-container-title:Ann Neurol.

Author:

Mendell Jerry R.,Shilling Chris,Leslie Nancy D.,Flanigan Kevin M.,al-Dahhak Roula,Gastier-Foster Julie,Kneile Kelley,Dunn Diane M.,Duval Brett,Aoyagi Alexander,Hamil Cindy,Mahmoud Maha,Roush Kandice,Bird Lauren,Rankin Chelsea,Lilly Heather,Street Natalie,Chandrasekar Ram,Weiss Robert B.

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Reference46 articles.

1. Creatine phosphokinase levels in the newborn and their use in screening for Duchenne muscular dystrophy;Drummond;Arch Dis Child,1979

2. Feasibility of neonatal screening for Duchenne muscular dystrophy;Skinner;J Med Genet,1982

3. Screening for Duchenne muscular dystrophy: an improved screening test for creatine kinase and its application in an infant screening program;Scheuerbrandt;Muscle Nerve,1986

4. Gene studies in newborn males with Duchenne muscular dystrophy detected by neonatal screening;Greenberg;Lancet,1988

5. Duchenne muscular dystrophy: neonatal screening and prenatal diagnosis;Plauchu;Lancet,1989

Cited by 637 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Relationship between growth and ambulation loss in Duchenne muscular dystrophy boys on steroids;European Journal of Neurology;2024-09-09

2. Case Report: Acute myocarditis in a patient with Duchenne muscular dystrophy;Frontiers in Cardiovascular Medicine;2024-09-03

3. Cataloging health state utility estimates for Duchenne muscular dystrophy and related conditions;Health and Quality of Life Outcomes;2024-09-02

4. Early motor, cognitive, language, behavioural and social emotional development in infants and young boys with Duchenne Muscular Dystrophy- A systematic review;European Journal of Paediatric Neurology;2024-09

5. Corticosteroids for the treatment of Duchenne muscular dystrophy: a safety review;Expert Opinion on Drug Safety;2024-08-27